Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Genocea Biosciences (GNCA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 74,044
  • Shares Outstanding, K 14,050
  • Annual Sales, $ 0 K
  • Annual Income, $ -27,810 K
  • 60-Month Beta 2.80
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 13.30

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.78
  • Number of Estimates 2
  • High Estimate -0.72
  • Low Estimate -0.83
  • Prior Year -0.88
  • Growth Rate Est. (year over year) +11.36%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.04 +30.45%
on 05/24/19
11.28 -53.28%
on 06/03/19
-0.44 (-7.66%)
since 05/14/19
3-Month
4.04 +30.45%
on 05/24/19
11.28 -53.28%
on 06/03/19
-0.65 (-10.98%)
since 03/14/19
52-Week
2.24 +135.27%
on 12/31/18
11.28 -53.28%
on 06/03/19
-2.33 (-30.66%)
since 06/14/18

Most Recent Stories

More News
Thinking about buying stock in Aurora Cannabis, Cypress Semiconductor, Delmar Pharmaceuticals, Genocea Biosciences, or Stellar Biotech?

InvestorsObserver issues critical PriceWatch Alerts for ACB, CY, DMPI, GNCA, and SBOT.

ACBFF : 8.6900 (-12.80%)
GNCA : 5.27 (+0.57%)
CY : 22.06 (-0.41%)
Thinking about buying stock in Avon Products, Genocea Biosciences, L Brands, Netshoes, or Obalon Therapeutics?

InvestorsObserver issues critical PriceWatch Alerts for AVP, GNCA, LB, NETS, and OBLN.

OBLN : 0.68 (-13.98%)
NETS : 3.70 (-2.63%)
GNCA : 5.27 (+0.57%)
LB : 22.51 (+1.35%)
AVP : 3.82 (-1.80%)
Westleaf Selected for Manitoba Cannabis Store Licence

Opportunity to build retail store and online sales expands distribution footprint

WSLFF : 0.3040 (-13.14%)
GNCA : 5.27 (+0.57%)
EYEG : 0.23 (-3.85%)
FGEN : 40.68 (-1.57%)
FATE : 17.83 (+1.42%)
WL.VN : 0.415 (-8.79%)
Genocea Announces Research Collaboration with Iovance to Explore Development of Neoantigen-Targeted TIL (Tumor-Infiltrating Lymphocyte) Products

Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced a research collaboration with Iovance Biotherapeutics, Inc. to assess...

GNCA : 5.27 (+0.57%)
Genocea Announces Positive Interim Immunogenicity Data from GEN-009 Neoantigen Vaccine Phase 1/2a Clinical Trial

Post-vaccination immune responses detected to 93% of vaccine neoantigens

GNCA : 5.27 (+0.57%)
Detailed Research: Economic Perspectives on CAI International, Genocea Biosciences, RF Industries, and Bilibili Inc. Sponsored ADR -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CAI International, Inc. (NYSE:CAI),...

RFIL : 7.73 (-1.78%)
GNCA : 5.27 (+0.57%)
CAI : 23.55 (-0.42%)
BILI : 14.27 (-1.45%)
Genocea Biosciences: 1Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Genocea Biosciences Inc. (GNCA) on Tuesday reported a loss of $15.6 million in its first quarter.

GNCA : 5.27 (+0.57%)
Genocea to Host Quarterly Corporate Update Conference Call & Webcast on April 30th at 9:00 am ET

Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, will host its first-quarter 2019 financial results and corporate update conference...

GNCA : 5.27 (+0.57%)
Genocea to Present at 18th Annual Needham Healthcare Conference

Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that Chip Clark, president and chief executive officer, will present...

GNCA : 5.27 (+0.57%)
Genocea Presents Data at AACR 2019 Supporting Utility of ATLAS(TM) Platform in Predicting Melanoma Patient Response to Immune Checkpoint Inhibitors

Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing neoantigen cancer immunotherapies, today announced the presentation of data from ATLAS(TM), its ex vivo platform for comprehensively...

GNCA : 5.27 (+0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade GNCA with:

Business Summary

Genocea Biosciences, Inc. is involved in developing vaccines. The company's proprietary discovery platform consists of AnTigen Lead Acquisition System which designs vaccines that stimulate T cell immunity. Its product portfolio which are in different clinical trials consist of GEN-003, HSV-2 infections,...

See More

Key Turning Points

2nd Resistance Point 5.59
1st Resistance Point 5.43
Last Price 5.27
1st Support Level 5.08
2nd Support Level 4.89

See More

52-Week High 11.28
Fibonacci 61.8% 7.83
Fibonacci 50% 6.76
Fibonacci 38.2% 5.69
Last Price 5.27
52-Week Low 2.24

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar